Janssen Research & Development Issues Public Comment on FDA Notice
2020-10-15
zz-Public Comments2020-10-15
Targeted News Service
WASHINGTON, Oct. 15 -- Harindra Ranil Abeysinghe, vice president and head of regulatory affairs for oncology and diagnostics with Raritan, New Jersey-based Janssen Research and Development LLC., has i . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Oct. 15 -- Harindra Ranil Abeysinghe, vice president and head of regulatory affairs for oncology and diagnostics with Raritan, New Jersey-based Janssen Research and Development LLC., has i . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2020